1. Home
  2. Nation
  3. Ex-Chief of India Medical Association,Dr KK Aggarwal, dies of COVID-19

Ex-Chief of India Medical Association,Dr KK Aggarwal, dies of COVID-19

By Priyanka Verma 
Updated Date
Ex-Chief of India Medical Association,Dr KK Aggarwal, dies of COVID-19

A former national president of the Indian Medical Association Dr. KK Aggarwal breathed his last on Monday at Delhi’s All India Institute of Medical Sciences after fighting a long battle against the dealy Covid-19.

Also Read :- 'Delta Plus' variant of Covid-19 resistant to vaccines in India: Scientists

The Padma Shri award winner had been on ventilator support at Delhi’s AIIMS hospital for the past few days, according to his family.

Dr Aggarwal, 62, died at 11.30 pm on Monday “after a lengthy battle with Covid”, said an official statement on his Twitter account. He had taken both vaccine doses.

“Ever since he became a doctor, Padma Shri Dr KK Aggarwal has dedicated his life to the welfare of the public and raising health awareness. Even during the pandemic, he made constant efforts to educate the masses and was able to reach out to over 100 million people through numerous videos and educational programs and saved countless lives,” said the statement.

A leading cardiologist and the head of the Heart Care Foundation of India, Dr. Aggarwal was the recipient of many awards in his career. He received the Dr. BC Roy Award in 2005 and the Padma Shree in 2010. He did his schooling in Delhi and completed his MBBS from Nagpur University.

Since the pandemic broke out last year, he had been vocal on various aspects of the coronavirus and had posted several videos and statements to raise public awareness. After he took his second vaccine dose in February and had posted a Q and A video on Facebook to address hesitancy and misapprehensions.

“Ever since he became a doctor, Padma Shri Dr. KK Aggarwal has dedicated his life to the welfare of the public and raising health awareness.” wrote his family in a statement following his demise.

Also Read :- Novavax Covid vaccine, to be made in India by SII, Shows 90.4% efficacy in US trial

Further reading:
For the latest news and reviews, follow us on Facebook and Twitter ...
X